BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 29128836)

  • 1. Characterization of liposome-containing SPIONs conjugated with anti-CD20 developed as a novel theranostic agent for central nervous system lymphoma.
    Saesoo S; Sathornsumetee S; Anekwiang P; Treetidnipa C; Thuwajit P; Bunthot S; Maneeprakorn W; Maurizi L; Hofmann H; Rungsardthong RU; Saengkrit N
    Colloids Surf B Biointerfaces; 2018 Jan; 161():497-507. PubMed ID: 29128836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of therapeutic effect of CD20-targeted immunoliposome in primary central nervous system lymphoma.
    Thumrongsiri N; Dana P; Bawab R; Tanyapanyachon P; Treetidnipa C; Saengkrit N; Sathornsumetee S
    Biomed Pharmacother; 2022 Jun; 150():112979. PubMed ID: 35461090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiopep-2 conjugated nanoparticles loaded with doxorubicin for the treatment of primary central nervous system lymphoma.
    Shi XX; Miao WM; Pang DW; Wu JS; Tong QS; Li JX; Luo JQ; Li WY; Du JZ; Wang J
    Biomater Sci; 2020 Mar; 8(5):1290-1297. PubMed ID: 31899467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Superparamagnetic iron oxide nanoparticles conjugated with folic acid for dual target-specific drug delivery and MRI in cancer theranostics.
    Huang Y; Mao K; Zhang B; Zhao Y
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):763-771. PubMed ID: 27770953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted cell uptake of a noninternalizing antibody through conjugation to iron oxide nanoparticles in primary central nervous system lymphoma.
    Wang T; Kievit FM; Veiseh O; Arami H; Stephen ZR; Fang C; Liu Y; Ellenbogen RG; Zhang M
    World Neurosurg; 2013; 80(1-2):134-41. PubMed ID: 23298674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles.
    Zheng XC; Ren W; Zhang S; Zhong T; Duan XC; Yin YF; Xu MQ; Hao YL; Li ZT; Li H; Liu M; Li ZY; Zhang X
    Int J Nanomedicine; 2018; 13():1495-1504. PubMed ID: 29559778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis-promoting effect of rituximab-conjugated magnetic nanoprobes on malignant lymphoma cells with CD20 overexpression.
    Song L; Zhang W; Chen H; Zhang X; Wu H; Ma M; Wang Z; Gu N; Zhang Y
    Int J Nanomedicine; 2019; 14():921-936. PubMed ID: 30787607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostic, pH-Responsive, Doxorubicin-Loaded Nanoparticles Inducing Active Targeting and Apoptosis for Advanced Gastric Cancer.
    Ma H; Liu Y; Shi M; Shao X; Zhong W; Liao W; Xing MM
    Biomacromolecules; 2015 Dec; 16(12):4022-31. PubMed ID: 26477267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer.
    Azhdarzadeh M; Atyabi F; Saei AA; Varnamkhasti BS; Omidi Y; Fateh M; Ghavami M; Shanehsazzadeh S; Dinarvand R
    Colloids Surf B Biointerfaces; 2016 Jul; 143():224-232. PubMed ID: 27015647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glioma-targeted dual functionalized thermosensitive Ferri-liposomes for drug delivery through an in vitro blood-brain barrier.
    Shi D; Mi G; Shen Y; Webster TJ
    Nanoscale; 2019 Aug; 11(32):15057-15071. PubMed ID: 31369016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glioma-Targeted Delivery of a Theranostic Liposome Integrated with Quantum Dots, Superparamagnetic Iron Oxide, and Cilengitide for Dual-Imaging Guiding Cancer Surgery.
    Xu HL; Yang JJ; ZhuGe DL; Lin MT; Zhu QY; Jin BH; Tong MQ; Shen BX; Xiao J; Zhao YZ
    Adv Healthc Mater; 2018 May; 7(9):e1701130. PubMed ID: 29350498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges.
    Laurent S; Saei AA; Behzadi S; Panahifar A; Mahmoudi M
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1449-70. PubMed ID: 24870351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in superparamagnetic iron oxide nanoparticles (SPIONs) for in vitro and in vivo cancer nanotheranostics.
    Kandasamy G; Maity D
    Int J Pharm; 2015 Dec; 496(2):191-218. PubMed ID: 26520409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing superparamagnetic iron oxide nanoparticles as drug carriers using an in vitro blood-brain barrier model.
    Shi D; Mi G; Bhattacharya S; Nayar S; Webster TJ
    Int J Nanomedicine; 2016; 11():5371-5379. PubMed ID: 27799764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation and evaluation of APTES-PEG coated iron oxide nanoparticles conjugated to rhenium-188 labeled rituximab.
    Azadbakht B; Afarideh H; Ghannadi-Maragheh M; Bahrami-Samani A; Asgari M
    Nucl Med Biol; 2017 May; 48():26-30. PubMed ID: 28189044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beyond Oncological Hyperthermia: Physically Drivable Magnetic Nanobubbles as Novel Multipurpose Theranostic Carriers in the Central Nervous System.
    Ficiarà E; Ansari SA; Argenziano M; Cangemi L; Monge C; Cavalli R; D'Agata F
    Molecules; 2020 Apr; 25(9):. PubMed ID: 32365941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF1 Receptor Targeted Theranostic Nanoparticles for Targeted and Image-Guided Therapy of Pancreatic Cancer.
    Zhou H; Qian W; Uckun FM; Wang L; Wang YA; Chen H; Kooby D; Yu Q; Lipowska M; Staley CA; Mao H; Yang L
    ACS Nano; 2015 Aug; 9(8):7976-91. PubMed ID: 26242412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain and bone cancer targeting by a ferrofluid composed of superparamagnetic iron-oxide/silica/carbon nanoparticles (earthicles).
    Wu VM; Huynh E; Tang S; Uskoković V
    Acta Biomater; 2019 Apr; 88():422-447. PubMed ID: 30711662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of multifunctional Janus nanoparticles on the basis of SPIONs as targeted drug delivery system.
    Shaghaghi B; Khoee S; Bonakdar S
    Int J Pharm; 2019 Mar; 559():1-12. PubMed ID: 30664992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New Pharmacokinetic Model Describing the Biodistribution of Intravenously and Intratumorally Administered Superparamagnetic Iron Oxide Nanoparticles (SPIONs) in a GL261 Xenograft Glioblastoma Model.
    Klapproth AP; Shevtsov M; Stangl S; Li WB; Multhoff G
    Int J Nanomedicine; 2020; 15():4677-4689. PubMed ID: 32669844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.